SAN FRANCISCO, July 25 - Affymetrix yesterday reported a bump up in revenue, decreased losses, and a slight increase in R&D for the second quarter.
Revenue for the period ended June 30 rose to $70.7 million, including $5.6 million from wafers sales from Perlegen Sciences, compared to total revenue of $49.5 million for the second quarter of 2001, the company said.
R&D spending rose to $17.3 million from $16.5 million for the same period a year ago, and net loss decreased to $1.6 million, or $.03 per share, in the second quarter 2002 compared to $9.1 million, or $.16 per share, in the year-ago period.
Affy also reported $134.8 million in cash and cash equivalents at the end on June 2002.
Click here for more information.